Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Diclofenac (75mg/ml)
Therapeutic Category
Analgesics, Orthopedics, Rheumatology, Anti-Inflammatories
Dosage Form
Injection
Packaging Type
Ampule
Packaging
10x1ml
Price
₹29/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Decplist AQ Injection is a powerful non-steroidal anti-inflammatory drug (NSAID) that contains Diclofenac, a potent agent for reducing inflammation and relieving pain. It is commonly used for the treatment of acute pain conditions such as postoperative pain, musculoskeletal pain, and pain associated with trauma, as well as in the management of various inflammatory disorders. Diclofenac works by inhibiting the enzymes responsible for the production of prostaglandins, substances that promote inflammation, pain, and fever in the body.
This injection provides fast-acting relief from pain and inflammation, and it is often used in a hospital or clinical setting under the supervision of healthcare professionals. Decplist AQ is typically administered through intramuscular or intravenous injection, depending on the severity of the condition.
Used in the treatment of acute pain, inflammatory disorders, arthritis, post-surgical pain, and sports injuries.
May include nausea, local injection site reaction, dizziness, or gastric irritation. Prolonged use can affect kidney or gastrointestinal health.
Should be administered under medical supervision. Not recommended for patients with known NSAID allergy, peptic ulcer, or severe renal or hepatic impairment.
Store below 25°C. Protect from light and do not freeze. Keep out of reach of children.
Composition : Diclofenac diethylamine (1.16% w/v) + Linseed Oil (3% w/v) + Methyl Salicylate (10% w/v) + Menthol (5% w/v)
Composition : Diclofenac (50mg) + Serratiopeptidase (10mg)
Composition : Chlorzoxazone (250mg) + Diclofenac (50mg) + Paracetamol (325mg)
Composition : Diclofenac (50mg) + Paracetamol (325mg)
Composition : Diclofenac (50mg) + Paracetamol (325mg) + Serratiopeptidase (10mg)
Composition : Diclofenac diethylamine (1.16% w/w) + Linseed Oil (3% w/w) + Methyl Salicylate (10% w/w) + Menthol (0.5% w/w)
Composition : Diclofenac diethylamine (1.16% w/w) + Thiocolchicoside (0.125% w/w) + Linseed Oil (3.0% w/w) + Methyl Salicylate (10.0% w/w) + Menthol (5.0% w/w)
Composition : Diclofenac (100mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Diclofenac 75mg Injection has strong demand in the hospital, orthopedic, and emergency care segment, making it a high-utility product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in acute pain management, post-operative pain, arthritis, musculoskeletal disorders, trauma cases, and inflammatory conditions. It is widely used in hospitals, clinics, and emergency care settings.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Diclofenac 75mg Injection with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady hospital procurement, repeat institutional demand, and strong market acceptance in orthopedic and emergency care segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this injectable pain management formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.